These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 190058)

  • 1. Somatostatin: a review of its effects especially in human beings.
    Hansen AP; Lundbaek K
    Diabete Metab; 1976 Dec; 2(4):203-18. PubMed ID: 190058
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dissociated effects of somatostatin analogs on arginine-induced insulin, glucagon and growth hormone release in acromegalic patients.
    Wajchenberg BL; Cesar FP; Leme CE; Borghi VC; Souza VC; Souza IT; Neto DG; Germek OA; Coy DH; Comaru-Schally AM
    Horm Metab Res; 1983 Oct; 15(10):471-4. PubMed ID: 6139329
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Editorial: Somatostatin: newcomer from the hypothalamus.
    Brazeau P; Gullemin R
    N Engl J Med; 1974 Apr; 290(17):963-4. PubMed ID: 4206096
    [No Abstract]   [Full Text] [Related]  

  • 4. Somatostatin, basic and clinical studies. A review.
    Schally AV; Meyers CA
    Mater Med Pol; 1980; 12(1-2):28-32. PubMed ID: 6120265
    [No Abstract]   [Full Text] [Related]  

  • 5. [Role of somatostatin in the diabetic].
    Basdevant A
    Nouv Presse Med; 1977 Mar; 6(10):841-5. PubMed ID: 322089
    [No Abstract]   [Full Text] [Related]  

  • 6. Somatostatin and pancreatic polypeptide secretion: effects of glucagon, insulin, and arginine.
    Weir GC; Samols E; Loo S; Patel YC; Gabbay KH
    Diabetes; 1979 Jan; 28(1):35-40. PubMed ID: 759249
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The effects of somatostatin in acromegaly].
    Schaison G; Roger M; Milhaud G
    Nouv Presse Med; 1976 Mar; 5(10):629-32. PubMed ID: 772591
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of somatostatin on plasma glucose and glucagon levels in human diabetes mellitus. Pathophysiologic and therapeutic implications.
    Gerich JE; Lorenzi M; Schneider V; Karam JH; Rivier J; Guillemin R; Forsham PH
    N Engl J Med; 1974 Sep; 291(11):544-7. PubMed ID: 4604408
    [No Abstract]   [Full Text] [Related]  

  • 9. Somatostatin and the endocrine pancreas.
    Gerich JE
    Curr Top Mol Endocrinol; 1976; 3():127-43. PubMed ID: 211005
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The somatostatin analogue SMS 201-995 in acromegaly: prolonged, preferential suppression of growth hormone but not pancreatic hormones.
    George SR; Hegele RA; Burrow GN
    Clin Invest Med; 1987 Jul; 10(4):309-15. PubMed ID: 2888554
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of somatostatin on the rise of growth hormone and glucagon secretion induced by arginine and L-dopa in diabetic patients.
    Hansen AP; Christensen SE; Lundbaek K
    Scand J Clin Lab Invest; 1975 May; 35(3):205-10. PubMed ID: 1153917
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of physiologic levels of glucagon and growth hormone on human carbohydrate and lipid metabolism. Studies involving administration of exogenous hormone during suppression of endogenous hormone secretion with somatostatin.
    Gerich JE; Lorenzi M; Bier DM; Tsalikian E; Schneider V; Karam JH; Forsham PH
    J Clin Invest; 1976 Apr; 57(4):875-84. PubMed ID: 820717
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Somatostatin--clinical implications.
    Ciba Found Symp; 1976; 41():313-50. PubMed ID: 780078
    [No Abstract]   [Full Text] [Related]  

  • 14. Differences between somatostatin-28 and somatostatin-14 with respect to their biological effects in healthy humans and acromegalics.
    Hadjidakis DJ; Raptis SA; Souvatzoglou A; Karaiskos C; Diamantopoulos EJ; Moulopoulos SD
    Clin Physiol Biochem; 1986; 4(6):372-83. PubMed ID: 2880690
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Somatostatin: diabetes and acromegaly.
    Gerich JE
    Adv Intern Med; 1977; 22():251-72. PubMed ID: 190870
    [No Abstract]   [Full Text] [Related]  

  • 16. Somatostatin: its role in health and disease.
    Gottesman IS; Mandarino LJ; Gerich JE
    Spec Top Endocrinol Metab; 1982; 4():177-243. PubMed ID: 6134345
    [No Abstract]   [Full Text] [Related]  

  • 17. Direct effects of catecholamines, thyrotropin-releasing hormone, and somatostatin on growth hormone and prolactin secretion from adenomatous and nonadenomatous human pituitary cells in culture.
    Ishibashi M; Yamaji T
    J Clin Invest; 1984 Jan; 73(1):66-78. PubMed ID: 6140273
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Somatostatin--a hypothalamic factor inhibiting the secretion of growth hormone].
    Lankosz-Lauterbach J
    Pediatr Pol; 1977 Aug; 52(8):919-23. PubMed ID: 333364
    [No Abstract]   [Full Text] [Related]  

  • 19. Non-pituitary actions of somatostatin. A review on the therapeutic role of SMS 201-995 (sandostatin).
    Lamberts SW
    Acta Endocrinol Suppl (Copenh); 1986; 276():41-55. PubMed ID: 2875590
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Acromegaly. Recent physiopathological and therapeutic acquisitions].
    Silvestrini F
    Minerva Med; 1979 Mar; 70(15):1065-8. PubMed ID: 108635
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.